DIA - FDA CDER Small Business and Industry Assistance (SBIA) - Shared - Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies

FDA CDER Small Business and Industry Assistance (SBIA)

Overview Locations Contacts Featured Content

Back

Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies - Webinar

This webinar will discuss the final guidance for the industry Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies which was published in July 2024.

Our FDA subject matter experts will also address recommendations from the guidance including, deciding whether and when to conduct the study, as well as how to design and report results from a human radiolabeled mass balance study.

Earn 1.0 CME/CPE/CNE!

Register here ➡️ Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies - 11/12/2024 | FDA⁠⁠⁠⁠⁠⁠⁠

Invite Supplier

Invite Supplier

Invite Supplier

Invite Supplier

Possible Duplicates

Update Company Details

Terms and Conditions

Available Companies

Select the listing you wish to view or edit.

Video Recommendation

FDA CDER Small Business and Industry Assistance (SBIA)

FDA CDER Small Business and Industry Assistance (SBIA)

Add Image Caption

Send Message

Send Message

View Email Address

Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies - Webinar

Send Message

Share via

Claim Listing

Report a Problem

Select the nature of the problem

Create a Post

Add to Lists